Related references
Note: Only part of the references are listed.Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial
Ann-Lii Cheng et al.
EUROPEAN JOURNAL OF CANCER (2012)
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma according to Child-Pugh classification
Daisuke Miyaki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Evaluation of the mRECIST and alpha-Fetoprotein Ratio for Stratification of the Prognosis of Advanced-Hepatocellular-Carcinoma Patients Treated with Sorafenib
Tomokazu Kawaoka et al.
ONCOLOGY (2012)
Hepatocellular Carcinoma With Extrahepatic Metastasis Clinical Features and Prognostic Factors
Koji Uchino et al.
CANCER (2011)
Intra-arterial 5-fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases
Yoshio Katamura et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2010)
High Serum Des-gamma-carboxy Prothrombin Level Predicts Poor Prognosis After Radiofrequency Ablation of Hepatocellular Carcinoma
Masahiro Kobayashi et al.
CANCER (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Diagnosis of hepatocellular carcinoma
Asmaa I. Gomaa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Lens culinaris agglutinin-reactive α-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis:: a histopathological study of surgically resected hepatocellular carcinoma
Hisamitsu Miyaaki et al.
JOURNAL OF GASTROENTEROLOGY (2007)
Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma
Kiminori Uka et al.
JOURNAL OF GASTROENTEROLOGY (2007)
Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma
Kiminori Uka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion
S Obi et al.
CANCER (2006)
Management of hepatocellular carcinoma in Japan
K Okita
JOURNAL OF GASTROENTEROLOGY (2006)
Clinical features of hepatocellular carcinoma with extrahepatic metastases
M Natsuizaka et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil;: role of type I interferon receptor expression
H Ota et al.
BRITISH JOURNAL OF CANCER (2005)
Extrahepatic spread from hepatocellular carcinoma: Who are candidates for aggressive anti-cancer treatment?
H Ishii et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2004)
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
SM Wilhelm et al.
CANCER RESEARCH (2004)
The des-γ-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma
S Nagaoka et al.
CANCER (2003)
Combined Intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches
M Sakon et al.
CANCER (2002)
Share Paper
